K.L. Lewis

446 total citations
24 papers, 291 citations indexed

About

K.L. Lewis is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, K.L. Lewis has authored 24 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 12 papers in Cardiology and Cardiovascular Medicine and 7 papers in Internal Medicine. Recurrent topics in K.L. Lewis's work include Pulmonary Hypertension Research and Treatments (12 papers), Cardiovascular Issues in Pregnancy (9 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). K.L. Lewis is often cited by papers focused on Pulmonary Hypertension Research and Treatments (12 papers), Cardiovascular Issues in Pregnancy (9 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). K.L. Lewis collaborates with scholars based in United States. K.L. Lewis's co-authors include Anton N. Hasso, John R. Thompson, Kim Jordan, L Cousins, Daniel B. Hinshaw, Albrecht Will, Abhinav Chandra, Amre Nouh and Alexander T. Limkakeng and has published in prestigious journals such as Neurology, Annals of Emergency Medicine and Yearbook of Medicine.

In The Last Decade

K.L. Lewis

18 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.L. Lewis United States 7 166 91 73 63 47 24 291
Nasir Sıvrı Türkiye 11 140 0.8× 149 1.6× 11 0.2× 27 0.4× 27 0.6× 17 363
L Del Guercio Italy 5 89 0.5× 39 0.4× 142 1.9× 32 0.5× 23 0.5× 10 274
Takeshi Uwatoko Japan 10 137 0.8× 41 0.5× 34 0.5× 7 0.1× 124 2.6× 22 240
Juan Diaz‐Cartelle United States 16 527 3.2× 174 1.9× 29 0.4× 24 0.4× 13 0.3× 30 759
Jerry Paul India 13 162 1.0× 94 1.0× 20 0.3× 6 0.1× 43 0.9× 67 419
Jeffrey Zahn United States 12 20 0.1× 78 0.9× 6 0.1× 35 0.6× 40 0.9× 18 364
Michael Spearman United States 6 47 0.3× 10 0.1× 89 1.2× 7 0.1× 144 3.1× 13 294
Farida Gadalla United States 12 72 0.4× 63 0.7× 5 0.1× 25 0.4× 15 0.3× 25 327
Frank P. McGrath Ireland 11 123 0.7× 10 0.1× 55 0.8× 4 0.1× 79 1.7× 23 346
Toshinori Nakahara Japan 13 104 0.6× 8 0.1× 24 0.3× 7 0.1× 187 4.0× 25 379

Countries citing papers authored by K.L. Lewis

Since Specialization
Citations

This map shows the geographic impact of K.L. Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.L. Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.L. Lewis more than expected).

Fields of papers citing papers by K.L. Lewis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.L. Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.L. Lewis. The network helps show where K.L. Lewis may publish in the future.

Co-authorship network of co-authors of K.L. Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of K.L. Lewis. A scholar is included among the top collaborators of K.L. Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.L. Lewis. K.L. Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chandra, Abhinav, K.L. Lewis, Amre Nouh, & Alexander T. Limkakeng. (2009). 380: Blatchford Clinical Risk Stratification Score May Be Used in an Observation Unit Setting to Risk Stratify Patients With Gastrointestinal Bleeding. Annals of Emergency Medicine. 54(3). S120–S120.
2.
Lewis, K.L.. (2008). Sitaxsentan Treatment for Patients With Pulmonary Arterial Hypertension Discontinuing Bosentan. Yearbook of Pulmonary Disease. 2008. 202–204. 3 indexed citations
3.
Lewis, K.L.. (2008). Favorable Effects of Inhaled Treprostinil in Severe Pulmonary Hypertension: Results From Randomized Controlled Pilot Studies. Yearbook of Pulmonary Disease. 2008. 194–196. 7 indexed citations
4.
Lewis, K.L.. (2008). Diagnostic Pathways in Acute Pulmonary Embolism: Recommendations of The PIOPED II Investigators. Yearbook of Pulmonary Disease. 2008. 210–214. 3 indexed citations
6.
Lewis, K.L.. (2008). Predictors of Outcome in Chronic Thromboembolic Pulmonary Hypertension. Yearbook of Pulmonary Disease. 2008. 208–209. 6 indexed citations
7.
Lewis, K.L.. (2008). Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. Yearbook of Medicine. 2008. 311–312. 1 indexed citations
8.
Lewis, K.L.. (2008). Quality of Life in Pulmonary Arterial Hypertension: Improvement and Maintenance With Bosentan. Yearbook of Pulmonary Disease. 2008. 196–197. 4 indexed citations
10.
Lewis, K.L.. (2007). Pulmonary Arterial Hypertension in France: Results from a National Registry. Yearbook of Pulmonary Disease. 2007. 182–183. 103 indexed citations
11.
Lewis, K.L.. (2007). Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Yearbook of Pulmonary Disease. 2007. 194–196.
12.
Lewis, K.L.. (2007). Massive Pulmonary Embolism. Yearbook of Pulmonary Disease. 2007. 180–182.
13.
Lewis, K.L.. (2007). A clinical study of hypersensitivity pneumonitis presumably caused by feather duvets. Yearbook of Pulmonary Disease. 2007. 157–158. 2 indexed citations
14.
Lewis, K.L.. (2007). Pleural Effusions in a Series of 181 Outpatients With Sarcoidosis. Yearbook of Pulmonary Disease. 2007. 156–157.
15.
Lewis, K.L.. (2007). Efficacy and Safety of Sildenafil Added to Treprostinil in Pulmonary Hypertension. Yearbook of Pulmonary Disease. 2007. 192–196. 1 indexed citations
16.
Lewis, K.L.. (2007). Transition from Intravenous Epoprostenol to Intravenous Treprostinil in Pulmonary Hypertension. Yearbook of Pulmonary Disease. 2007. 187–189.
17.
Lewis, K.L.. (2007). Efficacy of Long-term Subcutaneous Treprostinil Sodium Therapy in Pulmonary Hypertension. Yearbook of Pulmonary Disease. 2007. 186–189. 8 indexed citations
18.
Lewis, K.L.. (2006). New Predictors of Outcome in Idiopathic Pulmonary Arterial Hypertension. Yearbook of Pulmonary Disease. 2006. 160–161. 7 indexed citations
19.
Lewis, K.L.. (2006). Retinoids and Pulmonary Hypertension. Yearbook of Pulmonary Disease. 2006. 170–171. 1 indexed citations
20.
Will, Albrecht, K.L. Lewis, Daniel B. Hinshaw, et al.. (1987). Cerebral vasoconstriction in toxemia. Neurology. 37(9). 1555–1555. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026